Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video tool boosts thyroid pill adherence in new study

NCT ID NCT06205303

Disease control Sponsor: SingHealth Polyclinics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a patient decision aid—a short video—to help adults with hypothyroidism who were not getting enough thyroid hormone. The video explains the condition, the role of thyroxine, and factors that affect absorption. Researchers randomly assigned 236 patients to watch the video or receive usual care, then measured changes in medication adherence, knowledge, and quality of life. The goal is to empower patients to better manage their thyroid health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient decision aid (video)
What this could lead to
If successful, this video tool could help people with hypothyroidism take their medication more consistently, leading to better thyroid control and quality of life.
What could go wrong
This is a small, completed study in a single healthcare system. The video may not work as well in other settings or for all patients. It does not test a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

236 people

The number who actually took part.

Started

Mar 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Age ≥21 years * Able to read and speak English * Active patient with hypothyroidism at SingHealth Polyclinics (SHP) {had minimum of 2 follow-up visits at the respective study site in the last 12 months} * TSH \>3.70 milli-international units per liter (mIU/L) Exclusion Criteria: * Euthyroid state (TSH 0.65-3.70 mIU/L) * LT4 over-replacement (TSH \<0.65 mIU/L) * Individuals who are severely ill or with hearing impairment and mental disturbances * Pregnant women * Sick euthyroid syndrome

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypothyroidism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypothyroidism Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypothyroidism

Contacts and locations

Locations

  • SingHealth Polyclinics

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.